Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This double-blind, placebo-controlled, single ascending dose study is designed to demonstrate
safety, tolerability and pharmacokinetics of SKI-O-703 in healthy volunteers. The results of
this study will guide selection of dose levels for future multiple dose studies in healthy
volunteers and adult patients with moderately to severely active rheumatoid arthritis.